<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Traditional Korean medicines with <z:chebi fb="11" ids="22586">antioxidant</z:chebi> properties are believed to have potential therapeutic effects against <z:mp ids='MP_0003674'>oxidative stress</z:mp> in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> effects of Joongpoongtang 05 (JP05) were evaluated in rat middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="2" pm="."><plain>Male Sprague-Dawley rats treated with JP05 (100 and 200 mg/kg body weight, p.o.) for 5 days showed a reduction in <z:mpath ids='MPATH_124'>infarct</z:mpath> sizes and a decrease in oxidants after MCAO </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, a significant inhibition of enzymatic <z:chebi fb="11" ids="22586">antioxidants</z:chebi> in the ischemic cerebral cortex was observed </plain></SENT>
<SENT sid="4" pm="."><plain>Treatment with JP05 reversed the inhibition to <z:mpath ids='MPATH_458'>normal</z:mpath> levels </plain></SENT>
<SENT sid="5" pm="."><plain>In the <z:chebi fb="0" ids="16856">glutathione</z:chebi> system, the reduced <z:chebi fb="0" ids="16856">glutathione</z:chebi> (GSH) level was decreased while oxidized <z:chebi fb="0" ids="16856">glutathione</z:chebi> (GSSG) was increased in MCAO rats </plain></SENT>
<SENT sid="6" pm="."><plain>Treatment with JP05 increased the GSH/GSSG ratio and redox index by enhancing the synthesis of GSH from GSSG </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, in vitro studies showed that JP05 has strong <z:chebi fb="11" ids="22586">antioxidant</z:chebi> activity in the Trolox equivalent <z:chebi fb="11" ids="22586">antioxidant</z:chebi> capacity, oxygen radical absorbance capacity and 1,1-diphenyl-2-picrylhydrazyl radical assays </plain></SENT>
<SENT sid="8" pm="."><plain>The present findings suggest that JP05 treatment can contribute to a protective effect on <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> through <z:chebi fb="11" ids="22586">antioxidant</z:chebi> mechanisms </plain></SENT>
</text></document>